Relationship between Conflicts of Interest and Research Results

Journal of General Internal Medicine

Volumn 19, Issue 1, 2004, Pages 51-56

  Friedman, Lee S ^a,b   Richter, Elihu D ^b  

^a Social Policy Research Institute   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Biomedical ethics; Conflict of interest; Funding; Publication bias; Research

Indexed keywords

CONFIDENCE INTERVAL; DRUG INDUSTRY; ETHICS; FINANCIAL MANAGEMENT; MEDICAL RESEARCH; PUBLICATION; REVIEW; SAMPLE SIZE; SCIENTIFIC LITERATURE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICS, RESEARCH; HUMANS; PERIODICALS; PUBLICATION BIAS; RESEARCH SUPPORT;

EID: 1242269436     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.30617.x     Document Type: Review

References (23)

1. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturer- supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154:157-63.
2. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med. 1986;1:155-8.
3. Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract. 2001;18:565-8.
4. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennet CL. Evaluation of conflict of interest in economic analyses of new drugs in oncology. JAMA. 1999;282:1453-7.
5. Clifford TJ, Barrowman NJ, Moher D. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study. BMC Health Serv Res. 2002;2:18.
6. ISI Journal Citation Report 2000. Available at: http://www.isinet.com/ isi/. Accessed February 5, 2002.
7. N Engl J Med. 2001;344-345:1-1978 and 1-1882.
8. J Am Med Assoc. 2001;285-286:1-3129 and 1-3119.
9. Abramson JH. Survey Methods in Community Medicine, 4th edn. Churchill Livingstone;1990:ch. 2.
10. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Updated October 2001.
11. Drug Monitor. IMS Health Global Services. 2002. Available at: http://www.imshealth.com. Accessed July 17, 2002.
12. Holden C. NEJM admits breaking its own tough rules. Science. 2000;287:1573.
13. Thompson DF. Understanding financial conflicts of interest. NEJM. 1993;329:573-6.
14. Stelfox HT, Chua G, O'Rourke K, Detsky A. Conflict of interest in the debate over calcium-channel antagonists. NEJM. 1998;338:101-6.
15. 6/L CD4 counts: a randomized controlled trial. JAMA 2000;284:2193-202.
16. Dickersin K, Min Y, Meinert CL. Factors influencing publication of research results. JAMA. 1992;267:374-8.
17. Schulman K, Sulmasy DP, Roney D. Ethics, economics and the publication policies of major medical journals. JAMA. 1994;272:154-6.
18. Task Force on Financial Conflicts of Interest in Clinical Research. Protecting Subjects, Preserving Trust, Promoting Progress - Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research. Association of American Medical Colleges; 2001.
19. Boyd EA, Bero LA. Assessing faculty financial relationships with industry. JAMA. 2000;284:2209-14.
20. Korn D. Conflicts of interest in biomedical research. JAMA. 2000;285:2234-6.
21. Temptation to fudge scientific findings. The Virginian-Pilot and The Ledger-Star, Norfolk, Va. November 12, 2000.
22. Deangelis CD. Conflict of interest and the public trust. JAMA. 2000;284:2237-8.
23. Friedman Ross L. Correspondence to editor in reply to "Is Academic Medicine for Sale?" NEJM. 2000;342:508.